FA
Frances Arnold (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Generate Biomedicines, Inc. (GENB). The largest single filing was $185K of GENB (11,409 sh × $16.19, as filed), executed Oct 29. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$185K
shares × price, as filed
Last traded
Oct 29
Filed Nov 4
Median ADV $16.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $185K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
GENB
Generate Biomedicines, Inc.
GENB · 0 buys · 1 sell
1 filing
Recent filings
GENBSALE
Generate Biomedicines, Inc.
View filing →
$185K11,409 sh × $16.19
Exec Oct 29
Filed Nov 4 · 4:05 PM ET †